ONC - BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call Transcript
2025-08-06 13:36:36 ET
BeOne Medicines Ltd. (ONC)
Q2 2025 Earnings Call
August 6, 2025 8:00 A.M. ET
Company Participants
Aaron Rosenberg - Chief Financial Officer
Daniel Maller - Head of Investor Relations
John V. Oyler - Co-Founder, Executive Chairman & CEO
Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors
Matt Shaulis - General Manager of North America
Wang Lai - Global Head of R&D
Xiaobin Wu - President, COO & GM of China
Conference Call Participants
Dingding Shi - Jefferies LLC, Research Division
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division
Michael Werner Schmidt - Guggenheim Securities, LLC, Research Division
Reni John Benjamin - Citizens JMP Securities, LLC, Research Division
Sean M. Laaman - Morgan Stanley, Research Division
Yigal Dov Nochomovitz - Citigroup Inc., Research Division
Ziyi Chen - Goldman Sachs Group, Inc., Research Division
Presentation
Operator
Good day, everyone. Welcome to BeOne Q2 2025 Earnings Call Webcast. [Operator Instructions] At this time, I would like to turn the call over to the company.
Daniel Maller
Hello and welcome. Thanks for joining us today. I'm Dan Miller, Head of Investor Relations at BeOne Medicines. Before we begin, please note that you can find additional materials, including a replay of today's webcast and presentation on the Investor Relations section of our website, ir.beonemedicines.com....
BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call Transcript